Skip to content

Evaluation of Combination Nano micelle Curcumin with Triamcinolone Acetonide in Oral Lichen planus

Evaluation of Effectiveness of Combination Nano micelle Curcumin Gel %1with Triamcinolone Acetonide Mouthwash%0.1 in Oral Lichen planus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190523043678N1
Enrollment
50
Registered
2019-06-11
Start date
2018-10-17
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Lichen Planus. Lichen Planus

Interventions

Intervention 1: First intervention group: In this group, patients receiving 1% Nanocorcinem gel with triamcinolone mouthwash receive one-tenth of a percent for three weekly doses per week. (Half an ho

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with sympathetic lichen planus (erosive or atrophic) with burning or pain Clinical diagnosis (Wicham lines) and in cases where it was difficult to achieve a definitive diagnosis of the lesion, a histopathologic evaluation was used The patient has not been taking topical corticosteroid therapy over the past two weeks, he has not used systemic corticosteroids during the past month. The patient has not used Analgesic and anestheticpain

Exclusion criteria

Exclusion criteria: Patients with lichenoid lesions caused by drugs or dental materials pregnant or lactation Patients who have other lesions similar to systemic leukoplakia and systemic lupus in conjunction with lichen planus Historh of malignancy Non-cooperative patients and patients who do not take medication

Design outcomes

Primary

MeasureTime frame
Severity and size of the lesion. Timepoint: Base Day (0), Day 14, Day 28. Method of measurement: with a scaled abslang.;Reduction in severity of lessions. Timepoint: Base Day (0), Day 14, Day 28. Method of measurement: Efficacy Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahzad Gholami

Shahid Beheshti University of Medical Sciences

shahzad.kf@gmail.com+98 21 2990 2311

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026